This content requires a premium subscription.
Please log in or subscribe to continue.
FierceBiotech Radio
Novartis and Vertex score big approvals, Mylan runs into real estate controversy, and @brentlsaunders makes a splash on Twitter
Released: Jul 9, 2015
Fierce editors discuss a pair of major new drug approvals, a land deal scandal involving Mylan's global headquarters, and the CEO of Allergan's refreshing approach to Twitter.
Novartis and Vertex score big approvals, Mylan runs into real estate controversy, and @brentlsaunders makes a splash on Twitter
